Selected research
Market Structure
Global Plasma Proteomics Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Plasma Proteomics Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Plasma Proteomics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Plasma Proteomics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Plasma Proteomics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Plasma Proteomics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Plasma Proteomics Service include BostonGene, CellCarta, GENEWIZ (Azenta Life Sciences), CDI Labs, Biognosys, Discovery Life Sciences, Firalis Molecular Precision, Cell Signaling Technology (CST) and Sampled (Infinity Biologix), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Plasma Proteomics Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Plasma Proteomics Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Plasma Proteomics Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Plasma Proteomics Service market size, projected growth trends, production technologies, key applications, and end-use industries.
Plasma Proteomics Service Segment by Company
BostonGene
CellCarta
GENEWIZ (Azenta Life Sciences)
CDI Labs
Biognosys
Discovery Life Sciences
Firalis Molecular Precision
Cell Signaling Technology (CST)
Sampled (Infinity Biologix)
APTBIO
Sinotech Genomics
Biodesix
Panome Bio
Novogene
PTM BIO
BGI Genomics
Evotec
Metware Biotechnology
MRM Proteomics
Lc-Bio Technologies
Eurofins Scientific
MtoZ-Biolabs
Creative Proteomics
Macrogen
TATAA Biocenter
OmicScouts (Momentum Biotechnologies)
Precision Biomarker Laboratories (PBL)
Shanghai OE Biotech
RxCelerate
Proteomics International
Proteome Sciences
Westlake Omics
Crown Bioscience
VProteomics
Shanghai Majorbio Bio-Pharm
Applied Biomics
Sapient Bioanalytics
Allumiqs
MS Bioworks
Shanghai Bioprofile
Cosmos Wisdom
Olink (Thermo Fisher Scientific)
SomaLogic (Illumina)
Labcorp
Plasma Proteomics Service Segment by Type
Discovery Plasma Proteomics
DIA Plasma Proteomics
TMT Plasma Proteomics
Targeted Plasma Proteomics
Others
Plasma Proteomics Service Segment by Application
Disease Biomarker Research
Drug Development
Clinical Research
Others
Plasma Proteomics Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Proteomics Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasma Proteomics Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Proteomics Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Plasma Proteomics Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Plasma Proteomics Service industry.
Chapter 3: Detailed analysis of Plasma Proteomics Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plasma Proteomics Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Discovery Plasma Proteomics
- DIA Plasma Proteomics
- TMT Plasma Proteomics
- Targeted Plasma Proteomics
- Others
Applications
- Disease Biomarker Research
- Drug Development
- Clinical Research
- Others
Companies covered
- BostonGene
- CellCarta
- GENEWIZ (Azenta Life Sciences)
- CDI Labs
- Biognosys
- Discovery Life Sciences
- Firalis Molecular Precision
- Cell Signaling Technology (CST)
- Sampled (Infinity Biologix)
- APTBIO
- Sinotech Genomics
- Biodesix
- Panome Bio
- Novogene
- PTM BIO
- BGI Genomics
- Evotec
- Metware Biotechnology
- MRM Proteomics
- Lc-Bio Technologies
- Eurofins Scientific
- MtoZ-Biolabs
- Creative Proteomics
- Macrogen
- TATAA Biocenter
- OmicScouts (Momentum Biotechnologies)
- Precision Biomarker Laboratories (PBL)
- Shanghai OE Biotech
- RxCelerate
- Proteomics International
- Proteome Sciences
- Westlake Omics
- Crown Bioscience
- VProteomics
- Shanghai Majorbio Bio-Pharm
- Applied Biomics
- Sapient Bioanalytics
- Allumiqs
- MS Bioworks
- Shanghai Bioprofile
- Cosmos Wisdom
- Olink (Thermo Fisher Scientific)
- SomaLogic (Illumina)
- Labcorp
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Plasma Proteomics Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Discovery Plasma Proteomics
- 1.2.3 DIA Plasma Proteomics
- 1.2.4 TMT Plasma Proteomics
- 1.2.5 Targeted Plasma Proteomics
- 1.2.6 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Plasma Proteomics Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Disease Biomarker Research
- 1.3.3 Drug Development
- 1.3.4 Clinical Research
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Plasma Proteomics Service Growth Trends by Region
- 1.5.1 Global Plasma Proteomics Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Plasma Proteomics Service Market Size by Region (2021-2026)
- 1.5.3 Plasma Proteomics Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Plasma Proteomics Service Market Dynamics
- 2.1 Plasma Proteomics Service Industry Trends
- 2.2 Plasma Proteomics Service Industry Drivers
- 2.3 Plasma Proteomics Service Industry Opportunities and Challenges
- 2.4 Plasma Proteomics Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Plasma Proteomics Service Revenue by Company (2021-2026)
- 3.2 Global Plasma Proteomics Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Plasma Proteomics Service Key Company Head office and Area Served
- 3.4 Global Plasma Proteomics Service Company, Product Type & Application
- 3.5 Global Plasma Proteomics Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Plasma Proteomics Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Plasma Proteomics Service Players Market Share by Revenue in 2025
- 3.6.3 2025 Plasma Proteomics Service Tier 1, Tier 2, and Tier 3
4 Plasma Proteomics Service Market by Type
- 4.1 Global Plasma Proteomics Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Plasma Proteomics Service Market Size by Type (2021-2032)
- 4.3 Global Plasma Proteomics Service Market Size Share by Type (2021-2032)
5 Plasma Proteomics Service Market by Application
- 5.1 Global Plasma Proteomics Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Plasma Proteomics Service Market Size by Application (2021-2032)
- 5.3 Global Plasma Proteomics Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 BostonGene
- 6.1.1 BostonGene Company Information
- 6.1.2 BostonGene Business Overview
- 6.1.3 BostonGene Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 BostonGene Plasma Proteomics Service Product Portfolio
- 6.1.5 BostonGene Recent Developments
- 6.2 CellCarta
- 6.2.1 CellCarta Company Information
- 6.2.2 CellCarta Business Overview
- 6.2.3 CellCarta Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 CellCarta Plasma Proteomics Service Product Portfolio
- 6.2.5 CellCarta Recent Developments
- 6.3 GENEWIZ (Azenta Life Sciences)
- 6.3.1 GENEWIZ (Azenta Life Sciences) Company Information
- 6.3.2 GENEWIZ (Azenta Life Sciences) Business Overview
- 6.3.3 GENEWIZ (Azenta Life Sciences) Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 GENEWIZ (Azenta Life Sciences) Plasma Proteomics Service Product Portfolio
- 6.3.5 GENEWIZ (Azenta Life Sciences) Recent Developments
- 6.4 CDI Labs
- 6.4.1 CDI Labs Company Information
- 6.4.2 CDI Labs Business Overview
- 6.4.3 CDI Labs Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 CDI Labs Plasma Proteomics Service Product Portfolio
- 6.4.5 CDI Labs Recent Developments
- 6.5 Biognosys
- 6.5.1 Biognosys Company Information
- 6.5.2 Biognosys Business Overview
- 6.5.3 Biognosys Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Biognosys Plasma Proteomics Service Product Portfolio
- 6.5.5 Biognosys Recent Developments
- 6.6 Discovery Life Sciences
- 6.6.1 Discovery Life Sciences Company Information
- 6.6.2 Discovery Life Sciences Business Overview
- 6.6.3 Discovery Life Sciences Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Discovery Life Sciences Plasma Proteomics Service Product Portfolio
- 6.6.5 Discovery Life Sciences Recent Developments
- 6.7 Firalis Molecular Precision
- 6.7.1 Firalis Molecular Precision Company Information
- 6.7.2 Firalis Molecular Precision Business Overview
- 6.7.3 Firalis Molecular Precision Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Firalis Molecular Precision Plasma Proteomics Service Product Portfolio
- 6.7.5 Firalis Molecular Precision Recent Developments
- 6.8 Cell Signaling Technology (CST)
- 6.8.1 Cell Signaling Technology (CST) Company Information
- 6.8.2 Cell Signaling Technology (CST) Business Overview
- 6.8.3 Cell Signaling Technology (CST) Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Cell Signaling Technology (CST) Plasma Proteomics Service Product Portfolio
- 6.8.5 Cell Signaling Technology (CST) Recent Developments
- 6.9 Sampled (Infinity Biologix)
- 6.9.1 Sampled (Infinity Biologix) Company Information
- 6.9.2 Sampled (Infinity Biologix) Business Overview
- 6.9.3 Sampled (Infinity Biologix) Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Sampled (Infinity Biologix) Plasma Proteomics Service Product Portfolio
- 6.9.5 Sampled (Infinity Biologix) Recent Developments
- 6.10 APTBIO
- 6.10.1 APTBIO Company Information
- 6.10.2 APTBIO Business Overview
- 6.10.3 APTBIO Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 APTBIO Plasma Proteomics Service Product Portfolio
- 6.10.5 APTBIO Recent Developments
- 6.11 Sinotech Genomics
- 6.11.1 Sinotech Genomics Company Information
- 6.11.2 Sinotech Genomics Business Overview
- 6.11.3 Sinotech Genomics Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Sinotech Genomics Plasma Proteomics Service Product Portfolio
- 6.11.5 Sinotech Genomics Recent Developments
- 6.12 Biodesix
- 6.12.1 Biodesix Company Information
- 6.12.2 Biodesix Business Overview
- 6.12.3 Biodesix Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Biodesix Plasma Proteomics Service Product Portfolio
- 6.12.5 Biodesix Recent Developments
- 6.13 Panome Bio
- 6.13.1 Panome Bio Company Information
- 6.13.2 Panome Bio Business Overview
- 6.13.3 Panome Bio Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Panome Bio Plasma Proteomics Service Product Portfolio
- 6.13.5 Panome Bio Recent Developments
- 6.14 Novogene
- 6.14.1 Novogene Company Information
- 6.14.2 Novogene Business Overview
- 6.14.3 Novogene Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Novogene Plasma Proteomics Service Product Portfolio
- 6.14.5 Novogene Recent Developments
- 6.15 PTM BIO
- 6.15.1 PTM BIO Company Information
- 6.15.2 PTM BIO Business Overview
- 6.15.3 PTM BIO Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 PTM BIO Plasma Proteomics Service Product Portfolio
- 6.15.5 PTM BIO Recent Developments
- 6.16 BGI Genomics
- 6.16.1 BGI Genomics Company Information
- 6.16.2 BGI Genomics Business Overview
- 6.16.3 BGI Genomics Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 BGI Genomics Plasma Proteomics Service Product Portfolio
- 6.16.5 BGI Genomics Recent Developments
- 6.17 Evotec
- 6.17.1 Evotec Company Information
- 6.17.2 Evotec Business Overview
- 6.17.3 Evotec Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Evotec Plasma Proteomics Service Product Portfolio
- 6.17.5 Evotec Recent Developments
- 6.18 Metware Biotechnology
- 6.18.1 Metware Biotechnology Company Information
- 6.18.2 Metware Biotechnology Business Overview
- 6.18.3 Metware Biotechnology Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 Metware Biotechnology Plasma Proteomics Service Product Portfolio
- 6.18.5 Metware Biotechnology Recent Developments
- 6.19 MRM Proteomics
- 6.19.1 MRM Proteomics Company Information
- 6.19.2 MRM Proteomics Business Overview
- 6.19.3 MRM Proteomics Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.19.4 MRM Proteomics Plasma Proteomics Service Product Portfolio
- 6.19.5 MRM Proteomics Recent Developments
- 6.20 Lc-Bio Technologies
- 6.20.1 Lc-Bio Technologies Company Information
- 6.20.2 Lc-Bio Technologies Business Overview
- 6.20.3 Lc-Bio Technologies Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.20.4 Lc-Bio Technologies Plasma Proteomics Service Product Portfolio
- 6.20.5 Lc-Bio Technologies Recent Developments
- 6.21 Eurofins Scientific
- 6.21.1 Eurofins Scientific Company Information
- 6.21.2 Eurofins Scientific Business Overview
- 6.21.3 Eurofins Scientific Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.21.4 Eurofins Scientific Plasma Proteomics Service Product Portfolio
- 6.21.5 Eurofins Scientific Recent Developments
- 6.22 MtoZ-Biolabs
- 6.22.1 MtoZ-Biolabs Company Information
- 6.22.2 MtoZ-Biolabs Business Overview
- 6.22.3 MtoZ-Biolabs Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.22.4 MtoZ-Biolabs Plasma Proteomics Service Product Portfolio
- 6.22.5 MtoZ-Biolabs Recent Developments
- 6.23 Creative Proteomics
- 6.23.1 Creative Proteomics Company Information
- 6.23.2 Creative Proteomics Business Overview
- 6.23.3 Creative Proteomics Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.23.4 Creative Proteomics Plasma Proteomics Service Product Portfolio
- 6.23.5 Creative Proteomics Recent Developments
- 6.24 Macrogen
- 6.24.1 Macrogen Company Information
- 6.24.2 Macrogen Business Overview
- 6.24.3 Macrogen Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.24.4 Macrogen Plasma Proteomics Service Product Portfolio
- 6.24.5 Macrogen Recent Developments
- 6.25 TATAA Biocenter
- 6.25.1 TATAA Biocenter Company Information
- 6.25.2 TATAA Biocenter Business Overview
- 6.25.3 TATAA Biocenter Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.25.4 TATAA Biocenter Plasma Proteomics Service Product Portfolio
- 6.25.5 TATAA Biocenter Recent Developments
- 6.26 OmicScouts (Momentum Biotechnologies)
- 6.26.1 OmicScouts (Momentum Biotechnologies) Company Information
- 6.26.2 OmicScouts (Momentum Biotechnologies) Business Overview
- 6.26.3 OmicScouts (Momentum Biotechnologies) Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.26.4 OmicScouts (Momentum Biotechnologies) Plasma Proteomics Service Product Portfolio
- 6.26.5 OmicScouts (Momentum Biotechnologies) Recent Developments
- 6.27 Precision Biomarker Laboratories (PBL)
- 6.27.1 Precision Biomarker Laboratories (PBL) Company Information
- 6.27.2 Precision Biomarker Laboratories (PBL) Business Overview
- 6.27.3 Precision Biomarker Laboratories (PBL) Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.27.4 Precision Biomarker Laboratories (PBL) Plasma Proteomics Service Product Portfolio
- 6.27.5 Precision Biomarker Laboratories (PBL) Recent Developments
- 6.28 Shanghai OE Biotech
- 6.28.1 Shanghai OE Biotech Company Information
- 6.28.2 Shanghai OE Biotech Business Overview
- 6.28.3 Shanghai OE Biotech Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.28.4 Shanghai OE Biotech Plasma Proteomics Service Product Portfolio
- 6.28.5 Shanghai OE Biotech Recent Developments
- 6.29 RxCelerate
- 6.29.1 RxCelerate Company Information
- 6.29.2 RxCelerate Business Overview
- 6.29.3 RxCelerate Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.29.4 RxCelerate Plasma Proteomics Service Product Portfolio
- 6.29.5 RxCelerate Recent Developments
- 6.30 Proteomics International
- 6.30.1 Proteomics International Company Information
- 6.30.2 Proteomics International Business Overview
- 6.30.3 Proteomics International Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.30.4 Proteomics International Plasma Proteomics Service Product Portfolio
- 6.30.5 Proteomics International Recent Developments
- 6.31 Proteome Sciences
- 6.31.1 Proteome Sciences Company Information
- 6.31.2 Proteome Sciences Business Overview
- 6.31.3 Proteome Sciences Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.31.4 Proteome Sciences Plasma Proteomics Service Product Portfolio
- 6.31.5 Proteome Sciences Recent Developments
- 6.32 Westlake Omics
- 6.32.1 Westlake Omics Company Information
- 6.32.2 Westlake Omics Business Overview
- 6.32.3 Westlake Omics Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.32.4 Westlake Omics Plasma Proteomics Service Product Portfolio
- 6.32.5 Westlake Omics Recent Developments
- 6.33 Crown Bioscience
- 6.33.1 Crown Bioscience Company Information
- 6.33.2 Crown Bioscience Business Overview
- 6.33.3 Crown Bioscience Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.33.4 Crown Bioscience Plasma Proteomics Service Product Portfolio
- 6.33.5 Crown Bioscience Recent Developments
- 6.34 VProteomics
- 6.34.1 VProteomics Company Information
- 6.34.2 VProteomics Business Overview
- 6.34.3 VProteomics Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.34.4 VProteomics Plasma Proteomics Service Product Portfolio
- 6.34.5 VProteomics Recent Developments
- 6.35 Shanghai Majorbio Bio-Pharm
- 6.35.1 Shanghai Majorbio Bio-Pharm Company Information
- 6.35.2 Shanghai Majorbio Bio-Pharm Business Overview
- 6.35.3 Shanghai Majorbio Bio-Pharm Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.35.4 Shanghai Majorbio Bio-Pharm Plasma Proteomics Service Product Portfolio
- 6.35.5 Shanghai Majorbio Bio-Pharm Recent Developments
- 6.36 Applied Biomics
- 6.36.1 Applied Biomics Company Information
- 6.36.2 Applied Biomics Business Overview
- 6.36.3 Applied Biomics Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.36.4 Applied Biomics Plasma Proteomics Service Product Portfolio
- 6.36.5 Applied Biomics Recent Developments
- 6.37 Sapient Bioanalytics
- 6.37.1 Sapient Bioanalytics Company Information
- 6.37.2 Sapient Bioanalytics Business Overview
- 6.37.3 Sapient Bioanalytics Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.37.4 Sapient Bioanalytics Plasma Proteomics Service Product Portfolio
- 6.37.5 Sapient Bioanalytics Recent Developments
- 6.38 Allumiqs
- 6.38.1 Allumiqs Company Information
- 6.38.2 Allumiqs Business Overview
- 6.38.3 Allumiqs Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.38.4 Allumiqs Plasma Proteomics Service Product Portfolio
- 6.38.5 Allumiqs Recent Developments
- 6.39 MS Bioworks
- 6.39.1 MS Bioworks Company Information
- 6.39.2 MS Bioworks Business Overview
- 6.39.3 MS Bioworks Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.39.4 MS Bioworks Plasma Proteomics Service Product Portfolio
- 6.39.5 MS Bioworks Recent Developments
- 6.40 Shanghai Bioprofile
- 6.40.1 Shanghai Bioprofile Company Information
- 6.40.2 Shanghai Bioprofile Business Overview
- 6.40.3 Shanghai Bioprofile Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.40.4 Shanghai Bioprofile Plasma Proteomics Service Product Portfolio
- 6.40.5 Shanghai Bioprofile Recent Developments
- 6.41 Cosmos Wisdom
- 6.42 Olink (Thermo Fisher Scientific)
- 6.43 SomaLogic (Illumina)
- 6.44 Labcorp
7 North America
- 7.1 North America Plasma Proteomics Service Market Size (2021-2032)
- 7.2 North America Plasma Proteomics Service Market Size by Type
- 7.2.1 North America Plasma Proteomics Service Market Size by Type (2021-2026)
- 7.2.2 North America Plasma Proteomics Service Market Size by Type (2027-2032)
- 7.2.3 North America Plasma Proteomics Service Market Share by Type (2021-2032)
- 7.3 North America Plasma Proteomics Service Market Size by Application
- 7.3.1 North America Plasma Proteomics Service Market Size by Application (2021-2026)
- 7.3.2 North America Plasma Proteomics Service Market Size by Application (2027-2032)
- 7.3.3 North America Plasma Proteomics Service Market Share by Application (2021-2032)
- 7.4 North America Plasma Proteomics Service Market Size by Country
- 7.4.1 North America Plasma Proteomics Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Plasma Proteomics Service Market Size by Country (2021-2026)
- 7.4.3 North America Plasma Proteomics Service Market Size by Country (2027-2032)
- 7.4.4 North America Plasma Proteomics Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Plasma Proteomics Service Market Size (2021-2032)
- 8.2 Europe Plasma Proteomics Service Market Size by Type
- 8.2.1 Europe Plasma Proteomics Service Market Size by Type (2021-2026)
- 8.2.2 Europe Plasma Proteomics Service Market Size by Type (2027-2032)
- 8.2.3 Europe Plasma Proteomics Service Market Share by Type (2021-2032)
- 8.3 Europe Plasma Proteomics Service Market Size by Application
- 8.3.1 Europe Plasma Proteomics Service Market Size by Application (2021-2026)
- 8.3.2 Europe Plasma Proteomics Service Market Size by Application (2027-2032)
- 8.3.3 Europe Plasma Proteomics Service Market Share by Application (2021-2032)
- 8.4 Europe Plasma Proteomics Service Market Size by Country
- 8.4.1 Europe Plasma Proteomics Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Plasma Proteomics Service Market Size by Country (2021-2026)
- 8.4.3 Europe Plasma Proteomics Service Market Size by Country (2027-2032)
- 8.4.4 Europe Plasma Proteomics Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Plasma Proteomics Service Market Size (2021-2032)
- 9.2 China Plasma Proteomics Service Market Size by Type
- 9.2.1 China Plasma Proteomics Service Market Size by Type (2021-2026)
- 9.2.2 China Plasma Proteomics Service Market Size by Type (2027-2032)
- 9.2.3 China Plasma Proteomics Service Market Share by Type (2021-2032)
- 9.3 China Plasma Proteomics Service Market Size by Application
- 9.3.1 China Plasma Proteomics Service Market Size by Application (2021-2026)
- 9.3.2 China Plasma Proteomics Service Market Size by Application (2027-2032)
- 9.3.3 China Plasma Proteomics Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Plasma Proteomics Service Market Size (2021-2032)
- 10.2 Asia Plasma Proteomics Service Market Size by Type
- 10.2.1 Asia Plasma Proteomics Service Market Size by Type (2021-2026)
- 10.2.2 Asia Plasma Proteomics Service Market Size by Type (2027-2032)
- 10.2.3 Asia Plasma Proteomics Service Market Share by Type (2021-2032)
- 10.3 Asia Plasma Proteomics Service Market Size by Application
- 10.3.1 Asia Plasma Proteomics Service Market Size by Application (2021-2026)
- 10.3.2 Asia Plasma Proteomics Service Market Size by Application (2027-2032)
- 10.3.3 Asia Plasma Proteomics Service Market Share by Application (2021-2032)
- 10.4 Asia Plasma Proteomics Service Market Size by Country
- 10.4.1 Asia Plasma Proteomics Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Plasma Proteomics Service Market Size by Country (2021-2026)
- 10.4.3 Asia Plasma Proteomics Service Market Size by Country (2027-2032)
- 10.4.4 Asia Plasma Proteomics Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Plasma Proteomics Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Plasma Proteomics Service Market Size by Type
- 11.2.1 South America, Middle East & Africa Plasma Proteomics Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Plasma Proteomics Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Plasma Proteomics Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Plasma Proteomics Service Market Size by Application
- 11.3.1 South America, Middle East & Africa Plasma Proteomics Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Plasma Proteomics Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Plasma Proteomics Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Plasma Proteomics Service Market Size by Country
- 11.4.1 South America, Middle East & Africa Plasma Proteomics Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Plasma Proteomics Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Plasma Proteomics Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Plasma Proteomics Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst